FUTURA MEDICAL LS-002
GYXStockF
€0.00 ▼ 20.00%
12 juin 2026
G
FUTURA MEDICAL LS-002
€0.00 ▼ 20.00%
12 juin 2026
GYXStockF

01 / À propos

Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company's lead product includes Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

Arberion
Loading market data